Journal Information
Vol. 20. Issue 8.
Pages 452-453 (October 2024)
Share
Share
Download PDF
More article options
Visits
43
Vol. 20. Issue 8.
Pages 452-453 (October 2024)
Case report
Adalimumab treatment of resistant chondrocalcinosis
Tratamiento con adalimumab de la condrocalcinosis resistente
Visits
43
Fatih Tastekin
Corresponding author
fatihtastekin@gmail.com

Corresponding author.
, Kenan Aksu
Ege University Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Abstract

In this article, we present a case of resistant chondrocalcinosis who had a good response with 40mg subcutaneous adalimumab. To our knowledge, this is the first report using adalimumab successfully in severe CPDD. Anti-TNF therapy can be a good therapeutic option for second line therapy in CPPD.

Keywords:
Calcium pyrophosphate
Chondrocalcinosis
Tumor necrosis factor-alpha
Adalimumab
Resumen

En este artículo, presentamos un caso de condrocalcinosis resistente que tuvo una buena respuesta con 40mg de adalimumab subcutáneo. Hasta donde sabemos, este es el primer informe en el que se utiliza adalimumab con éxito en la enfermedad por depósitos de cristales de pirofosfato de calcio dihidratado (CPPD) grave. El tratamiento anti-TNF puede ser una buena opción terapéutica de segunda línea en la CPPD.

Palabras clave:
Pirofosfato cálcico
Condrocalcinosis
Factor de necrosis tumoral alfa
Adalimumab

Article

These are the options to access the full texts of the publication Reumatología Clínica (English Edition)
Member
If you are member of Sociedad Española de Reumatología (SER) or the Colegio Mexicano de Reumatología (CMR):
Please go to the member area of SER or CMR and log in.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Reumatología Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?